Form 8-K - Current report:
SEC Accession No. 0000950170-22-023837
Filing Date
2022-11-09
Accepted
2022-11-09 16:07:59
Documents
13
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grph-20221109.htm   iXBRL 8-K 55810
2 EX-99.1 grph-ex99_1.htm EX-99.1 379762
  Complete submission text file 0000950170-22-023837.txt   574962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20221109_lab.xml EX-101.LAB 14572
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20221109.xsd EX-101.SCH 2466
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20221109_pre.xml EX-101.PRE 10675
7 EXTRACTED XBRL INSTANCE DOCUMENT grph-20221109_htm.xml XML 5077
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 221372593
SIC: 2836 Biological Products, (No Diagnostic Substances)